Overall Cost of DMTs Stable 2018–2020, Study Finds
News
The overall cost of disease-modifying therapies for multiple sclerosis (MS) in the U.S. remained stable from 2018 to 2020, according to pharmacy and medical claims data from Prime Therapeutics’ insured ... Read more